Literature DB >> 31638835

Prevalence and Electronic Health Record-Based Phenotype of Loss-of-Function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Genes.

Eric D Carruth1,2, Wilson Young3, Dominik Beer3, Cynthia A James4, Hugh Calkins4, Linyuan Jing1,2, Sushravya Raghunath1,2, Dustin N Hartzel2, Joseph B Leader2, H Lester Kirchner2, Diane T Smelser5, David J Carey5, Melissa A Kelly6, Amy C Sturm6, Amro Alsaid3, Brandon K Fornwalt1,2,3,7, Christopher M Haggerty1,2,3.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with variants in desmosome genes. Secondary findings of pathogenic/likely pathogenic variants, primarily loss-of-function (LOF) variants, are recommended for clinical reporting; however, their prevalence and associated phenotype in a general clinical population are not fully characterized.
METHODS: From whole-exome sequencing of 61 019 individuals in the DiscovEHR cohort, we screened for putative loss-of-function variants in PKP2, DSC2, DSG2, and DSP. We evaluated measures from prior clinical ECG and echocardiograms, manually over-read to evaluate ARVC diagnostic criteria, and performed a PheWAS (phenome-wide association study). Finally, we estimated expected penetrance using Bayesian inference.
RESULTS: One hundred forty individuals (0.23%; 59±18 years old at last encounter; 33% male) had an ARVC variant (G+). None had an existing diagnosis of ARVC in the electronic health record, nor significant differences in prior ECG or echocardiogram findings compared with matched controls without variants. Several G+ individuals satisfied major repolarization (n=4) and ventricular function (n=5) criteria, but this prevalence matched controls. PheWAS showed no significant associations of other heart disease diagnoses. Combining our best genetic and disease prevalence estimates yields an estimated penetrance of 6.0%.
CONCLUSIONS: The prevalence of ARVC loss-of-function variants is ≈1:435 in a general clinical population of predominantly European descent, but with limited electronic health record-based evidence of phenotypic association in our population, consistent with a low penetrance estimate. Prospective deep phenotyping and longitudinal follow-up of a large sequenced cohort is needed to determine the true clinical relevance of an incidentally identified ARVC loss-of-function variant.

Entities:  

Keywords:  desmosomes; echocardiography; electronic health records; genomics; whole exome sequencing

Year:  2019        PMID: 31638835      PMCID: PMC6876858          DOI: 10.1161/CIRCGEN.119.002579

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  29 in total

1.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

Authors:  Michael J Ackerman; Silvia G Priori; Stephan Willems; Charles Berul; Ramon Brugada; Hugh Calkins; A John Camm; Patrick T Ellinor; Michael Gollob; Robert Hamilton; Ray E Hershberger; Daniel P Judge; Hervè Le Marec; William J McKenna; Eric Schulze-Bahr; Chris Semsarian; Jeffrey A Towbin; Hugh Watkins; Arthur Wilde; Christian Wolpert; Douglas P Zipes
Journal:  Heart Rhythm       Date:  2011-08       Impact factor: 6.343

2.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.

Authors:  Domenico Corrado; Cristina Basso; Andrea Pavei; Pierantonio Michieli; Maurizio Schiavon; Gaetano Thiene
Journal:  JAMA       Date:  2006-10-04       Impact factor: 56.272

3.  Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital.

Authors:  Stefan Peters; Martina Trümmel; Werner Meyners
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

4.  Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.

Authors:  Sara L Van Driest; Quinn S Wells; Sarah Stallings; William S Bush; Adam Gordon; Deborah A Nickerson; Jerry H Kim; David R Crosslin; Gail P Jarvik; David S Carrell; James D Ralston; Eric B Larson; Suzette J Bielinski; Janet E Olson; Zi Ye; Iftikhar J Kullo; Noura S Abul-Husn; Stuart A Scott; Erwin Bottinger; Berta Almoguera; John Connolly; Rosetta Chiavacci; Hakon Hakonarson; Laura J Rasmussen-Torvik; Vivian Pan; Stephen D Persell; Maureen Smith; Rex L Chisholm; Terrie E Kitchner; Max M He; Murray H Brilliant; John R Wallace; Kimberly F Doheny; M Benjamin Shoemaker; Rongling Li; Teri A Manolio; Thomas E Callis; Daniela Macaya; Marc S Williams; David Carey; Jamie D Kapplinger; Michael J Ackerman; Marylyn D Ritchie; Joshua C Denny; Dan M Roden
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

5.  Yield of serial evaluation in at-risk family members of patients with ARVD/C.

Authors:  Anneline S J M te Riele; Cynthia A James; Neda Rastegar; Aditya Bhonsale; Brittney Murray; Crystal Tichnell; Daniel P Judge; David A Bluemke; Stefan L Zimmerman; Ihab R Kamel; Hugh Calkins; Harikrishna Tandri
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

6.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

Authors:  Cynthia A James; Aditya Bhonsale; Crystal Tichnell; Brittney Murray; Stuart D Russell; Harikrishna Tandri; Ryan J Tedford; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2013-07-17       Impact factor: 24.094

7.  Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.

Authors:  Suraj Kapa; David J Tester; Benjamin A Salisbury; Carole Harris-Kerr; Manish S Pungliya; Marielle Alders; Arthur A M Wilde; Michael J Ackerman
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

8.  Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes?

Authors:  Barry J Maron; Tammy S Haas; Emily R Duncanson; Ross F Garberich; Andrew M Baker; Shannon Mackey-Bojack
Journal:  Am J Cardiol       Date:  2016-02-01       Impact factor: 2.778

9.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

Authors:  Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins
Journal:  Genet Med       Date:  2016-08-17       Impact factor: 8.822

10.  Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing.

Authors:  Christopher M Haggerty; Cynthia A James; Hugh Calkins; Crystal Tichnell; Joseph B Leader; Dustin N Hartzel; Christopher D Nevius; Sarah A Pendergrass; Thomas N Person; Marci Schwartz; Marylyn D Ritchie; David J Carey; David H Ledbetter; Marc S Williams; Frederick E Dewey; Alexander Lopez; John Penn; John D Overton; Jeffrey G Reid; Matthew Lebo; Heather Mason-Suares; Christina Austin-Tse; Heidi L Rehm; Brian P Delisle; Daniel J Makowski; Vishal C Mehra; Michael F Murray; Brandon K Fornwalt
Journal:  Genet Med       Date:  2017-05-04       Impact factor: 8.822

View more
  17 in total

1.  Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association.

Authors:  Andrew P Landstrom; Jeffrey J Kim; Bruce D Gelb; Benjamin M Helm; Prince J Kannankeril; Christopher Semsarian; Amy C Sturm; Martin Tristani-Firouzi; Stephanie M Ware
Journal:  Circ Genom Precis Med       Date:  2021-08-20

2.  Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.

Authors:  Ravi A Shah; Babken Asatryan; Ghaith Sharaf Dabbagh; Nay Aung; Mohammed Y Khanji; Luis R Lopes; Stefan van Duijvenboden; Anthony Holmes; Daniele Muser; Andrew P Landstrom; Aaron Mark Lee; Pankaj Arora; Christopher Semsarian; Virend K Somers; Anjali T Owens; Patricia B Munroe; Steffen E Petersen; C Anwar A Chahal
Journal:  Circulation       Date:  2022-06-16       Impact factor: 39.918

3.  Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population.

Authors:  Eric D Carruth; Maria Qureshi; Amro Alsaid; Melissa A Kelly; Hugh Calkins; Brittney Murray; Crystal Tichnell; Amy C Sturm; Aris Baras; H Lester Kirchner; Brandon K Fornwalt; Cynthia A James; Christopher M Haggerty
Journal:  Circ Genom Precis Med       Date:  2022-06-14

4.  The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care.

Authors:  Lauren E Parker; Andrew P Landstrom
Journal:  Prog Pediatr Cardiol       Date:  2021-07-01

5.  Population Prevalence of Premature Truncating Variants in Plakophilin-2 and Association With Arrhythmogenic Right Ventricular Cardiomyopathy: A UK Biobank Analysis.

Authors:  Robyn J Hylind; Alexandre C Pereira; Daniel Quiat; Stephanie F Chandler; Thomas M Roston; William T Pu; Vassilios J Bezzerides; Jonathan G Seidman; Christine E Seidman; Dominic J Abrams
Journal:  Circ Genom Precis Med       Date:  2022-05-10

Review 6.  Epidemiology of the inherited cardiomyopathies.

Authors:  William J McKenna; Daniel P Judge
Journal:  Nat Rev Cardiol       Date:  2020-09-07       Impact factor: 32.419

Review 7.  Promise and Peril of Population Genomics for the Development of Genome-First Approaches in Mendelian Cardiovascular Disease.

Authors:  Victoria N Parikh
Journal:  Circ Genom Precis Med       Date:  2021-02-01

8.  Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies.

Authors:  Jordan E Ezekian; Catherine Rehder; Priya S Kishnani; Andrew P Landstrom
Journal:  Circ Genom Precis Med       Date:  2021-08-13

9.  Genetic counseling for patients with positive genomic screening results: Considerations for when the genetic test comes first.

Authors:  Marci L B Schwartz; Adam H Buchanan; Miranda L G Hallquist; Christopher M Haggerty; Amy C Sturm
Journal:  J Genet Couns       Date:  2021-03-31       Impact factor: 2.717

10.  Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.

Authors:  Eric D Carruth; Dominik Beer; Amro Alsaid; Marci L B Schwartz; Megan McMinn; Melissa A Kelly; Adam H Buchanan; Christopher D Nevius; Hugh Calkins; Cynthia A James; Brittney Murray; Crystal Tichnell; Martin E Matsumura; H Lester Kirchner; Brandon K Fornwalt; Amy C Sturm; Christopher M Haggerty
Journal:  Circ Genom Precis Med       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.